NCT06708689View on ClinicalTrials.gov

Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments

Active, not recruitingOBSERVATIONAL

Enrollment

240

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

March 3, 2025

Conditions

Home Parenteral NutritionIntestinal FailureCentral LineBotriomycomaInfectionSepsisAntibiotics

Trial Locations (1)

Unknown

Hôpital Mère-Enfant, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER